Use of carbamazepine and lamotrigine in a Taiwanese diabetic patient with bipolar disorder.
Kuo-Chun
KC
Chao
Mong-Liang
ML
Lu
Winston W
WW
Shen
D018692:Antimanic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000150:complications* / Q000188:drug therapy*; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D048909:Diabetes Complications / Q000139:chemically induced*; D004359:Drug Therapy, Combination; D059910:HLA-B15 Antigen / Q000235:genetics; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D008875:Middle Aged; D013262:Stevens-Johnson Syndrome / Q000150:complications; D014227:Triazines / Q000009:adverse effects* / Q000627:therapeutic use
D018692:Antimanic Agents; D059910:HLA-B15 Antigen; D014227:Triazines; D002220:Carbamazepine; D000077213:Lamotrigine